MON-652 The Prevalence and Clinical Characteristics of Adult Patients Presenting with Sodium-Glucose Co-Transporter-2 Inhibitor Associated Euglycemic Diabetic Ketoacidosis

Background: Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT-2i) have been associated with euglycemic diabetic ketoacidosis (EuDKA). The pathophysiology is related to decrease insulin secretion given glucosuria and lower insulin to glucagon ratio, resulting in enhanced lipolysis and ketogenesis at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Alexa, Mohammed, Arifuddin Saad, Raut, Amol, Moore, Sarah, Awad, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209581/
http://dx.doi.org/10.1210/jendso/bvaa046.848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209581/
http://dx.doi.org/10.1210/jendso/bvaa046.848

Ejemplares similares